Paradigm Biopharmaceuticals Ltd (ASX:PAR)
Pharmaceuticals, Biotechnology & Life Sciences
share price: (EoD)
earnings per share:
dividends per share:
Paradigm Biopharmaceuticals Ltd (ASX:PAR) has repurposed an anti-inflammatory drug called pentosan polysulphate sodium (PPS) to treat multiple new indications, including Osteoarthritis.
Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price
Paradigm Biopharmaceuticals Ltd (ASX:PAR) passive income
Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price news
ASX Growth Shares
Paradigm (ASX:PAR) share price drops on drug application update
The share price of Paradigm Biopharmaceuticals Ltd (ASX: PAR) is down today on an update of its new drug application. What does this mean for the Paradigm share price?
April 26, 2021
Today's ASX news
S&P/ASX 200 daily recap: PAR, QBE & BXB
Making ASX 200 news today was Paradigm Biopharmaceuticals Ltd (ASX:PAR), QBE Insurance Group Ltd (ASX:QBE) and Brambles Limited (ASX:BXB).
February 17, 2020
Today's ASX news
Paradigm Biopharmaceuticals Ltd (PAR) share price falls on HY report
The Paradigm Biopharmaceuticals (ASX: PAR) share price was trading 1.4% lower today following the release of its half-year financial report on Friday afternoon.
February 17, 2020
